GSK raises guidance
It looks like GSK may have found its blockbuster. Arexvy, the world’s first RSV vaccine for older adults has been approved in the U.S. and Japan.
Source: wfmz.com
First Half Operating News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from First Half Operating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In First Half Operating Today - Breaking & Trending Today